WittCM, BalneavesLG, CardosoMJ, et al.A comprehensive definition for integrative oncology. J Natl Cancer Inst Monogr, 2017; 2017(52):lgx012; doi: 10.1093/jncimonographs/lgx012.
2.
CassilethBR, DengGE, GomezJE, et al.Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 2007; 132(3Suppl.):340S–354S; doi: 10.1378/chest.07-1389.
3.
DengGE, RauschSM, JonesLW, et al.Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2013; 143(5Suppl.):e420S–e436S; doi: 10.1378/chest.12-2364.
4.
DengGE, FrenkelM, CohenL, et al.Evidence-based clinical practice guidelines for integrative oncology: Complementary therapies and botanicals. J Soc Integr Oncol, 2009; 7(3):85–120, PMID: 19706235.
5.
GreenleeH, BalneavesLG, CarlsonLE, et al.Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr, 2014; 2014(50):346–358; doi: 10.1093/jncimonographs/lgu041.
6.
GreenleeH, DuPont-ReyesMJ, BalneavesLG, et al.Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin, 2017; 67(3):194–232; doi: 10.3322/caac.21397.
7.
LymanGH, GreenleeH, BohlkeK, et al.Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol, 2018; 36(25):2647–2655; doi: 10.1200/JCO.2018.79.2721.
8.
Ben-AryeE, PallerCJ, LopezAM, et al.The society for integrative oncology practice recommendations for online consultation and treatment during the COVID-19 pandemic. Support Care Cancer, 2021; 29(10):6155–6165; doi: 10.1007/s00520-021-06205-w.
